首页DEVA • IST
add
Deva Holding AS
昨日收盘价
₺66.65
当日价格范围
₺66.95 - ₺68.35
年度波幅
₺51.00 - ₺81.75
市值
134.81亿 TRY
平均交易量
60.82万
市盈率
-
股息率
-
主要交易所
IST
市场资讯
财务信息
损益表
收入
净收入
| (TRY) | 2025年12月info | 年同比变化 |
|---|---|---|
收入 | 54.91亿 | -2.19% |
经营支出 | 17.41亿 | 2.67% |
净收入 | -13.44亿 | -524.24% |
净利润率 | -24.48 | -537.50% |
每股收益 | — | — |
息税折旧摊销前利润 | 6.22亿 | -48.71% |
有效税率 | -294.28% | — |
资产负债表
总资产
负债总额
| (TRY) | 2025年12月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 35.93亿 | 26.49% |
总资产 | 376.26亿 | -3.31% |
负债总额 | 113.07亿 | -3.14% |
权益总额 | 263.20亿 | — |
发行在外的股份 | 2.00亿 | — |
市净率 | 0.51 | — |
资产回报率 | -0.61% | — |
资本回报率 | -0.70% | — |
现金流
现金净变动
| (TRY) | 2025年12月info | 年同比变化 |
|---|---|---|
净收入 | -13.44亿 | -524.24% |
来自运营的现金 | 14.93亿 | 27.32% |
投资现金 | -8.39亿 | -130.98% |
融资现金 | 2.61亿 | 117.90% |
现金净变动 | 8.86亿 | 206.74% |
自由现金流 | -1.65亿 | 95.31% |
简介
DEVA Holding A.Ş. is a leading Turkish pharmaceutical company founded in 1958. As of 2024, it ranked 3rd in unit sales and 6th in TL sales in Turkey’s pharmaceutical market.
The company operates three EU GMP- and US FDA-approved facilities in Çerkezköy and Kartepe, with an annual production capacity of 620 million units. DEVA’s portfolio covers 10 therapeutic areas, including cardiovascular, dermatology, ophthalmology, hematology, and anti-infectives, and includes 1,404 registered products across 82 countries.
Recognized as Turkey’s top pharmaceutical company in R&D spending by Turkishtime’s 2024 R&D 250 Report, DEVA employs over 500 researchers and 3,000 staff in total. Guided by sustainability and innovation, the company focuses on developing accessible, effective, and environmentally responsible healthcare solutions for both domestic and global markets. Wikipedia
成立时间
1958年9月22日
员工数量
3,023
